Publications
November 10, 2021

Construction and Evaluation of Interleukin 3 (IL3)-Zetakine–Redirected Cytolytic T Cells for Treatment of CD123-Expressing Acute Myeloid Leukemia

Platform, VCAR33

SITC – 2021 – Poster Presentation 871